India’s first mRNA vaccine by Gennova gets DCGI approval

Daily Current Affairs / India’s first mRNA vaccine by Gennova gets DCGI approval

Change Language English Hindi

Category : National Published on: July 01 2022

Share on facebook

India’s first indigenously developed mRNA vaccine against the COVID-19 gets the Emergency Use Authorization (EUA), to be sold under the brand name GEMCOVAC™-19 and will be rolled out soon.
The vaccine will be available for adults above 18 years of age.
It is a two-dose vaccine to be administered intramuscularly at 28 days apart.
GEMCOVAC-19™ is the very first mRNA vaccine developed in India and the only third mRNA vaccine to be approved for COVID-19 in the world.
It is developed by The Pune-based subsidiary of Emcure Pharmaceuticals Ltd, Gennova Biopharmaceuticals Ltd.

India contributes $500,000 to UN’s Counter-Terrorism Trust Fund.
Read More....
DRDO ties up with IIT Bhubaneswar to boost research in electronic warfare and AI surveillance.
Read More....
Indian Coast Guard signs MoU with Hindalco for indigenous marine-grade aluminium supply.
Read More....
US and Saudi Arabia sign historic $142 billion defense cooperation agreement.
Read More....
Indore declares itself India’s first beggar-free city after year-long campaign.
Read More....
SBI joins global top 100 firms in net profit, third Indian company to reach the mark.
Read More....
Harvansh Chawla named Chairman of BRICS Chamber of Commerce & Industry.
Read More....
Dr. Ajay Kumar assumes charge as Chairman of UPSC.
Read More....
QNB becomes first MEA bank to launch branch in India’s GIFT City.
Read More....
Saudi Arabia pushes civil nuclear programme under Vision 2030 to cut emissions.
Read More....

India’s first mRNA vaccine by Gennova gets DCGI approval